MAFG is a potential therapeutic target to restore chemosensitivity in cisplatin-resistant cancer cells by increasing reactive oxygen species

Adjuvant chemotherapy for solid tumors based on platinum-derived compounds such as cisplatin is the treatment of choice in most cases. Cisplatin triggers signaling pathways that lead to cell death, but it also induces changes in tumor cells that modify the therapeutic response, thereby leading to ci...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Transl Res
Main Authors: VERA-PUENTE, OLGA, RODRIGUEZ-ANTOLIN, CARLOS, SALGADO-FIGUEROA, ANA, MICHALSKA, PATRYCJA, PERNIA, OLGA, REID, BRETT M., ROSAS, ROCÍO, GARCIA-GUEDE, ALVARO, SACRISTÁN, SILVIA, JIMENEZ, JULIA, ESTEBAN-RODRIGUEZ, ISABEL, MARTIN, M. ELENA, SELLERS, THOMAS A., LEÓN, RAFAEL, GONZALEZ, VÍCTOR M., DE CASTRO, JAVIER, DE CACERES, INMACULADA IBANEZ
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7787305/
https://ncbi.nlm.nih.gov/pubmed/30053382
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trsl.2018.06.005
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados